Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion.
Ascites
/ metabolism
Cell Adhesion
/ drug effects
Cell Line, Tumor
Cytokines
/ metabolism
Epithelial Cells
/ metabolism
Female
Gene Expression Regulation, Neoplastic
/ drug effects
Humans
Hyaluronan Receptors
/ genetics
Integrin beta1
/ genetics
Intercellular Adhesion Molecule-1
/ genetics
Neoplasms, Mesothelial
/ drug therapy
Ovarian Neoplasms
/ drug therapy
Patients
Peritoneum
/ chemistry
Signal Transduction
/ genetics
cdc42 GTP-Binding Protein
/ genetics
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
04
2020
accepted:
07
08
2020
entrez:
3
12
2020
pubmed:
4
12
2020
medline:
16
1
2021
Statut:
epublish
Résumé
The presence of ascites in the peritoneal cavity leads to morphological and functional changes of the peritoneal mesothelial cell layer. Cells loose cell-cell interactions, rearrange their cytoskeleton, activate the production of fibronectin, and change their cell surface morphology in a proinflammatory environment. Moreover, ovarian cancer cell adhesion has been shown to be facilitated by these changes due to increased integrin- and CD44-mediated binding sites. In this study, the biological responsiveness of the human pleural mesothelial cell line MeT-5A to patient-derived and artificial ascites was studied in vitro and adhesion of ovarian cancer cells, i.e. SKOV-3 cells, investigated. Changes were mainly observed in cells exposed to artificial ascites containing higher cytokine concentrations than patient-derived ascites. Interestingly, reduced cell-cell interactions were already observed in untreated MeT-5A cells and effects on tight junction protein expression and permeability upon exposure to ascites were minor. Ascites induced upregulation of CDC42 effector protein 2 expression, which affects stress fiber formation, however significant F-actin reorganization was not observed. Moreover, fibronectin production remained unchanged. Analysis of mesothelial cell surface characteristics showed upregulated expression of intercellular adhesion molecule 1, slightly increased hyaluronic acid secretion and decreased microvillus expression upon exposure to ascites. Nevertheless, the observed changes were not sufficient to facilitate adhesion of SKOV-3 cells on MeT-5A cell layer. This study revealed that MeT-5A cells show a reduced biological responsiveness to the presence of ascites, in contrast to published studies on primary human peritoneal mesothelial cells.
Identifiants
pubmed: 33270665
doi: 10.1371/journal.pone.0241500
pii: PONE-D-20-12012
pmc: PMC7714103
doi:
Substances chimiques
CD44 protein, human
0
Cytokines
0
Hyaluronan Receptors
0
ICAM1 protein, human
0
Integrin beta1
0
Intercellular Adhesion Molecule-1
126547-89-5
cdc42 GTP-Binding Protein
EC 3.6.5.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0241500Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Respirology. 2002 Sep;7(3):171-91
pubmed: 12153683
J Cell Sci. 2004 Aug 1;117(Pt 17):3935-45
pubmed: 15265990
Am J Cancer Res. 2012;2(5):566-80
pubmed: 22957308
Nat Rev Cancer. 2013 Apr;13(4):273-82
pubmed: 23426401
Cancer Res. 1985 Sep;45(9):4330-3
pubmed: 4028018
Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):7900-4
pubmed: 1518810
Cell Physiol Biochem. 2012;30(1):49-60
pubmed: 22759955
BMC Cancer. 2014 Apr 24;14:288
pubmed: 24761768
J Cell Sci. 2002 Apr 1;115(Pt 7):1383-9
pubmed: 11896186
Pol Arch Med Wewn. 2008 May;118(5):307-13
pubmed: 18619182
Perit Dial Int. 1998 Jul-Aug;18(4):382-6
pubmed: 10505559
J Surg Oncol. 2009 Jun 1;99(7):424-7
pubmed: 19365809
Prostate. 2000 Feb 1;42(2):88-98
pubmed: 10617865
J Clin Invest. 2014 Oct;124(10):4614-28
pubmed: 25202979
Nat Cell Biol. 2012 Mar 18;14(4):355-65
pubmed: 22426077
Gastroenterology. 2004 Sep;127(3):937-49
pubmed: 15362048
Chin J Cancer. 2012 Aug;31(8):364-72
pubmed: 22739265
Int J Cancer. 2007 Oct 1;121(7):1463-72
pubmed: 17546601
J Exp Med. 1992 Oct 1;176(4):1165-74
pubmed: 1383376
Int J Biochem Cell Biol. 2009 Nov;41(11):2240-50
pubmed: 19427400
Oncogene. 2010 Sep 9;29(36):5006-18
pubmed: 20603617
Int J Mol Sci. 2012;13(9):11705-17
pubmed: 23109879
Opt Express. 2012 Sep 24;20(20):22158-71
pubmed: 23037364
Cancer. 1993 Oct 15;72(8):2433-40
pubmed: 8402460
Eur J Cancer. 2011 Aug;47(12):1883-9
pubmed: 21514148
Clin Exp Metastasis. 2004;21(1):39-47
pubmed: 15065601
Kidney Int. 1993 Jan;43(1):226-33
pubmed: 8433563
Cancer Res. 1993 Jan 15;53(2):388-92
pubmed: 8417831
Cell. 1997 Oct 17;91(2):231-41
pubmed: 9346240
Atherosclerosis. 2013 May;228(1):12-7
pubmed: 23384719
J Pathol. 1996 Nov;180(3):333-9
pubmed: 8958814
ScientificWorldJournal. 2002 Apr 05;2:892-925
pubmed: 12805946
Nat Rev Cancer. 2016 Jan;16(1):20-33
pubmed: 26678314
Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1201-1210
pubmed: 29842893
Cancer Res. 2009 Feb 15;69(4):1469-76
pubmed: 19208843
Br J Cancer. 2010 Feb 16;102(4):639-44
pubmed: 20087353
Mol Cell Biol. 1999 Sep;19(9):5913-22
pubmed: 10454538
BJOG. 2001 Aug;108(8):804-8
pubmed: 11510703
Biochem Pharmacol. 1997 Jan 24;53(2):149-60
pubmed: 9037247
Oncotarget. 2018 Sep 7;9(70):33416-33439
pubmed: 30279971
Philos Trans A Math Phys Eng Sci. 2016 Apr 13;374(2065):20150202
pubmed: 26953178
J Biol Chem. 2001 Feb 23;276(8):5570-6
pubmed: 11096075
EMBO Mol Med. 2012 Dec;4(12):1308-19
pubmed: 23143987
Int J Gynecol Cancer. 2014 Feb;24(2):192-200
pubmed: 24407573
Clin Exp Metastasis. 2008;25(4):289-304
pubmed: 18324357
Leukemia. 2003 Oct;17(10):2007-15
pubmed: 14513051
Nephrol Dial Transplant. 1999 May;14(5):1208-16
pubmed: 10344363
Cancer Discov. 2011 Jul;1(2):144-57
pubmed: 22303516
Anat Embryol (Berl). 2005 Feb;209(3):251-61
pubmed: 15662530
Virchows Arch. 2003 Nov;443(5):678-85
pubmed: 12898248
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Cancer Res. 1995 Apr 1;55(7):1452-7
pubmed: 7882352
J Intern Med. 1997 Jul;242(1):27-33
pubmed: 9260563
Nat Cell Biol. 2014 Jun;16(6):538-49
pubmed: 24776885
Cancer Metastasis Rev. 2012 Jun;31(1-2):397-414
pubmed: 22527451
Connect Tissue Res. 2015;56(5):403-13
pubmed: 26291767
Pancreas. 2006 May;32(4):396-402
pubmed: 16670622
Biointerphases. 2018 Sep 11;13(6):06D404
pubmed: 30205690
Perit Dial Int. 1999 May-Jun;19(3):211-20
pubmed: 10433157
Exp Cell Res. 1985 Oct;160(2):499-513
pubmed: 3899694
Front Oncol. 2013 Sep 25;3:256
pubmed: 24093089
J Natl Med Assoc. 2005 Jan;97(1):79-84
pubmed: 15719876
Stroke. 2002 Jun;33(6):1706-11
pubmed: 12053015
Gynecol Oncol. 2014 Jun;133(3):401-4
pubmed: 24878391
Gynecol Oncol. 2015 Aug;138(2):352-7
pubmed: 26001328
Mol Biol Cell. 1997 Feb;8(2):287-301
pubmed: 9190208
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16783-7
pubmed: 20837548
J Surg Res. 2008 Jun 1;147(1):23-33
pubmed: 17574577
J Pathol. 2001 Apr;193(4):530-7
pubmed: 11276014
Neuro Endocrinol Lett. 2010;31(3):375-83
pubmed: 20588232
Oncogene. 1999 Jan 7;18(1):269-75
pubmed: 9926943
Int J Biochem Cell Biol. 2004 Apr;36(4):621-42
pubmed: 15010328
PLoS One. 2013 Sep 19;8(9):e74624
pubmed: 24069325
Cell Commun Adhes. 2003 May-Jun;10(3):141-54
pubmed: 14668061
Kidney Int. 1996 Oct;50(4):1337-43
pubmed: 8887296